GSK-872 hydrochloride is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM. GSK-872 hydrochloride decreases the RIPK3-mediated necroptosis and subsequent cytoplasmic translocation and expression of HMGB1, as well as ameliorates brain edema and neurological deficits in early brain injury.
Molecular Weight | 419.95 |
CAS Number | 2703752-81-0 |
Solubility (25°C) | DMSO 10 mg/mL (ultrasonic and warming and heat to 60°C) Water 2.5 mg/mL (ultrasonic and warming and heat to 60°C) |
Storage | 2-8°C, dry, sealed |
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
Related RIPK Products |
---|
RIPK1-IN-12
RIPK1-IN-12 is a potent RIPK1 inhibitor. |
DNL747
DNL747 is an ASK1 and RIPK1 inhibitor for studies related to Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis. |
DNL104
DNL104 is a RIPK1 inhibitor that can be used in Alzheimer's disease related studies. |
mRNA-0184
mRNA-0184 is a relaxin mimetic and also a relaxin receptor-1 (RXFP1) agonist. |
AZD-3427
AZD-3427 is an RXFP1 agonist that may be used in studies related to cardiovascular disease. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.